Several other analysts have also issued reports on the company. Zacks Investment Research lowered Acadia Healthcare from a “hold” rating to a “sell” rating and set a $31.00 target price on the stock. in a report on Wednesday, August 7th. Raymond James lowered Acadia Healthcare from a “strong-buy” rating to an “outperform” rating and set a $45.00 target price on the stock. in a report on Wednesday, July 31st. Jefferies Financial Group set a $40.00 target price on Acadia Healthcare and gave the stock a “buy” rating in a report on Thursday, October 10th. BidaskClub lowered Acadia Healthcare from a “hold” rating to a “sell” rating in a research note on Tuesday, October 8th. Finally, UBS Group upped their price objective on Acadia Healthcare from $29.00 to $34.00 and gave the company a “neutral” rating in a research note on Friday, September 20th. Two analysts have rated the stock with a sell rating, seven have issued a hold rating and three have assigned a buy rating to the company. The company currently has an average rating of “Hold” and an average price target of $36.30.
ACHC traded up $0.31 on Monday, hitting $30.88. 435,544 shares of the company were exchanged, compared to its average volume of 862,347. Acadia Healthcare has a 12 month low of $24.27 and a 12 month high of $45.35. The company has a market cap of $2.69 billion, a PE ratio of 13.79, a PEG ratio of 1.35 and a beta of 0.72. The company has a debt-to-equity ratio of 1.53, a quick ratio of 1.09 and a current ratio of 1.09. The stock’s fifty day moving average is $30.05 and its 200-day moving average is $31.22.
Acadia Healthcare (NASDAQ:ACHC) last released its earnings results on Tuesday, July 30th. The company reported $0.61 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.59 by $0.02. Acadia Healthcare had a positive return on equity of 7.20% and a negative net margin of 6.80%. The business had revenue of $789.00 million for the quarter, compared to analyst estimates of $795.31 million. During the same quarter in the prior year, the company posted $0.70 earnings per share. Acadia Healthcare’s revenue was up 3.0% on a year-over-year basis. As a group, equities research analysts expect that Acadia Healthcare will post 2.13 EPS for the current fiscal year.
In other Acadia Healthcare news, CEO Debra K. Osteen acquired 20,000 shares of the company’s stock in a transaction on Thursday, September 5th. The shares were purchased at an average price of $26.53 per share, for a total transaction of $530,600.00. Following the completion of the purchase, the chief executive officer now directly owns 117,178 shares of the company’s stock, valued at $3,108,732.34. The transaction was disclosed in a document filed with the SEC, which is available through this link. 2.60% of the stock is owned by corporate insiders.
Large investors have recently added to or reduced their stakes in the business. Abrams Bison Investments LLC bought a new position in shares of Acadia Healthcare during the second quarter worth approximately $83,531,000. Nuveen Asset Management LLC bought a new position in shares of Acadia Healthcare during the second quarter worth approximately $8,508,000. Stephens Investment Management Group LLC increased its stake in shares of Acadia Healthcare by 13.8% during the third quarter. Stephens Investment Management Group LLC now owns 1,300,936 shares of the company’s stock worth $40,433,000 after purchasing an additional 158,081 shares during the period. GW&K Investment Management LLC increased its stake in shares of Acadia Healthcare by 31.6% during the second quarter. GW&K Investment Management LLC now owns 632,216 shares of the company’s stock worth $22,096,000 after purchasing an additional 151,737 shares during the period. Finally, Rock Springs Capital Management LP increased its stake in shares of Acadia Healthcare by 14.1% during the second quarter. Rock Springs Capital Management LP now owns 1,055,000 shares of the company’s stock worth $36,872,000 after purchasing an additional 130,000 shares during the period.
Acadia Healthcare Company Profile
Acadia Healthcare Company, Inc develops and operates inpatient psychiatric facilities, residential treatment centers, group homes, substance abuse facilities, and outpatient behavioral healthcare facilities to serve the behavioral health and recovery needs of communities in the United States, the United Kingdom, and Puerto Rico.
Featured Story: What is Green Investing?
To view ValuEngine’s full report, visit ValuEngine’s official website.
Receive News & Ratings for Acadia Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.